trending Market Intelligence /marketintelligence/en/news-insights/trending/mntcoeuvp2j7yfuycbmw0w2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Hologic wins $4.8M in patent case against Minerva Surgical

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Hologic wins $4.8M in patent case against Minerva Surgical

Hologic Inc. said it was awarded $4.8 million in damages for Minerva Surgical Inc.'s infringement of two patents related to Hologic's NovaSure uterine bleeding device.

The U.S. District Court for the District of Delaware found Minerva Surgical guilty in June and rejected the Redwood City, Calif.-based company's defenses to infringement.

Bedford, Mass.-based Hologic said it will seek an injunction to prevent Minerva from further infringing on the NovaSure-related patents in the U.S.

Hologic filed the case in 2015, alleging that Minerva Surgical's endometrial ablation system infringes on several of its patents. Hologic said it acquired the patents through its 2004 acquisition of Novacept Inc., whose former executive Csaba Truckai founded Minerva Surgical four years later.

Minerva Surgical also sued Hologic for patent infringement in 2017.